Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48701
Campo DC Valoridioma
dc.contributor.authorAragón-Sánchez, J.en_US
dc.contributor.authorLázaro-Martínez, J. L.en_US
dc.contributor.authorCabrera-Galván, J. J.en_US
dc.date.accessioned2018-11-24T00:11:19Z-
dc.date.available2018-11-24T00:11:19Z-
dc.date.issued2014en_US
dc.identifier.issn0742-3071en_US
dc.identifier.urihttp://hdl.handle.net/10553/48701-
dc.description.abstractBone biopsy with both microbiological and histopathological purposes has been established as a high-quality criterion for diagnosing osteomyelitis in the feet of patients with diabetes [1]. However, some controversies have been reported, making the interpretation of the results difficult. A group of authors reported that 29.1% of patients with positive cultures of bone specimens had no histopathological findings of osteomyelitis in one series of patients with diabetes undergoing surgery for foot infections. They also reported that 25% of patients with positive histology had negative cultures [2]. Other authors had also reported such controversies [3], even when advanced imaging was performed as a diagnostic tool [4]. Furthermore, the agreement between pathologists diagnosing osteomyelitis in the feet of patients with diabetes could be below the level of 'reference standard' [5]. Finally, little information exists about histopathology in cases of Charcot neuroarthropathy, and it is well known that the clinical and radiological differentiation between Charcot neuroarthropathy and osteomyelitis is sometimes difficult.en_US
dc.languageengen_US
dc.relation.ispartofDiabetic Medicineen_US
dc.sourceDiabetic Medicine[ISSN 0742-3071],v. 31, p. 113-116 (Enero 2014)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320714 Osteopatologíaen_US
dc.subject.otherOsteomyelitisen_US
dc.subject.otherDiabetic footen_US
dc.titleAdditional information on the role of histopathology in diagnosing diabetic foot osteomyelitisen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/dme.12283en_US
dc.identifier.scopus84890153216-
dc.contributor.authorscopusid6507768519-
dc.contributor.authorscopusid18434633300-
dc.contributor.authorscopusid6602257053-
dc.description.lastpage116en_US
dc.description.firstpage113en_US
dc.relation.volume31en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Comentarioen_US
dc.description.numberofpages4en_US
dc.utils.revisionen_US
dc.date.coverdateEnero 2014en_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,691-
dc.description.jcr3,115-
dc.description.sjrqQ1-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-4184-6403-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameCabrera Galván,Juan José-
Colección:Comentario
Vista resumida

Citas SCOPUSTM   

6
actualizado el 21-jul-2024

Citas de WEB OF SCIENCETM
Citations

6
actualizado el 21-jul-2024

Visitas

60
actualizado el 23-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.